High‐dose folic acid and cancer risk; unjustified concerns by von Wrede and colleagues regarding our paper

Author:

Bjørk Marte‐Helene12ORCID,Tomson Torbjörn3ORCID,Dreier Julie Werenberg4ORCID,Alvestad Silje15ORCID,Gilhus Nils Erik12ORCID,Gissler Mika67ORCID,Igland Jannicke8ORCID,Leinonen Maarit K.6ORCID,Sun Yuelian9ORCID,Vegrim Håkon Magne1ORCID,Zoega Helga1011ORCID,Christensen Jakob1213ORCID

Affiliation:

1. Department of Clinical Medicine University of Bergen Bergen Norway

2. Department of Neurology Haukeland University Hospital Bergen Norway

3. Department of Clinical Neuroscience Karolinska Institute Stockholm Sweden

4. National Centre for Register‐Based Research School of Business and Social Sciences Aarhus University Aarhus Denmark

5. National Centre for Epilepsy Oslo University Hospital Oslo Norway

6. Knowledge Brokers Finnish Institute for Health and Welfare Helsinki Finland

7. Institute of Molecular Medicine and Surgery Karolinska Institute Stockholm Sweden

8. Department of Global Public Health and Primary Care University of Bergen Bergen Norway

9. Department of Clinical Epidemiology Aarhus University Hospital Aarhus Denmark

10. School of Population Health, Faculty of Medicine & Health University of New South Wales Sydney Australia

11. Centre of Public Health Sciences, Faculty of Medicine University of Iceland Reykjavik Iceland

12. Department of Neurology Aarhus University Hospital Aarhus Denmark

13. Department of Clinical Medicine Aarhus University Aarhus Denmark

Abstract

AbstractWomen using antiseizure medication in pregnancy are often advised to use high doses of folic acid supplements (1mg to 5 mg) to reduce the risk of teratogenicity. Recently, we published a report showing an association between maternal prescription fill of high dose folic acid in relation to pregnancy and childhood cancer in the offspring. The report has sparked a debate about which dose of folic acid that should be recommended in pregnancy in women in need of antiseizure medication. In this Commentary, we explain our findings and the method used in our report, and answer recent questions that have emerged.

Funder

NordForsk

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3